These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17763836)

  • 1. Diet and lifestyle interventions in active surveillance patients with favorable-risk prostate cancer.
    Kenfield SA; Chang ST; Chan JM
    Curr Treat Options Oncol; 2007 Jun; 8(3):173-96. PubMed ID: 17763836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of dietary, nutritional, and physical activity interventions for the prevention of prostate cancer progression and mortality.
    Hackshaw-McGeagh LE; Perry RE; Leach VA; Qandil S; Jeffreys M; Martin RM; Lane JA
    Cancer Causes Control; 2015 Nov; 26(11):1521-50. PubMed ID: 26354897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of comprehensive lifestyle changes on telomerase activity and telomere length in men with biopsy-proven low-risk prostate cancer: 5-year follow-up of a descriptive pilot study.
    Ornish D; Lin J; Chan JM; Epel E; Kemp C; Weidner G; Marlin R; Frenda SJ; Magbanua MJM; Daubenmier J; Estay I; Hills NK; Chainani-Wu N; Carroll PR; Blackburn EH
    Lancet Oncol; 2013 Oct; 14(11):1112-1120. PubMed ID: 24051140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence review of active surveillance in men with localized prostate cancer.
    Ip S; Dahabreh IJ; Chung M; Yu WW; Balk EM; Iovin RC; Mathew P; Luongo T; Dvorak T; Lau J
    Evid Rep Technol Assess (Full Rep); 2011 Dec; (204):1-341. PubMed ID: 23126653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nutrition, physical activity, and lifestyle factors in prostate cancer prevention.
    Ballon-Landa E; Parsons JK
    Curr Opin Urol; 2018 Jan; 28(1):55-61. PubMed ID: 29049045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expectant management with selective delayed intervention for favorable-risk prostate cancer.
    Klotz LH; Choo R; Morton G; Danjoux C
    Can J Urol; 2002 Jun; 9 Suppl 1():2-7. PubMed ID: 12121587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lifestyle and health-related quality of life of men with prostate cancer managed with active surveillance.
    Daubenmier JJ; Weidner G; Marlin R; Crutchfield L; Dunn-Emke S; Chi C; Gao B; Carroll P; Ornish D
    Urology; 2006 Jan; 67(1):125-30. PubMed ID: 16413347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer progression and mortality: a review of diet and lifestyle factors.
    Peisch SF; Van Blarigan EL; Chan JM; Stampfer MJ; Kenfield SA
    World J Urol; 2017 Jun; 35(6):867-874. PubMed ID: 27518576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancer.
    Nelson EC; Rodriguez RL; Dawson K; Galvez AF; Evans CP
    Nutr Cancer; 2008; 60(3):301-12. PubMed ID: 18444164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical events in prostate cancer lifestyle trial: results from two years of follow-up.
    Frattaroli J; Weidner G; Dnistrian AM; Kemp C; Daubenmier JJ; Marlin RO; Crutchfield L; Yglecias L; Carroll PR; Ornish D
    Urology; 2008 Dec; 72(6):1319-23. PubMed ID: 18602144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in prostate gene expression in men undergoing an intensive nutrition and lifestyle intervention.
    Ornish D; Magbanua MJ; Weidner G; Weinberg V; Kemp C; Green C; Mattie MD; Marlin R; Simko J; Shinohara K; Haqq CM; Carroll PR
    Proc Natl Acad Sci U S A; 2008 Jun; 105(24):8369-74. PubMed ID: 18559852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of diet in men with early stage prostate cancer on active surveillance: rationale and design of the Men's Eating and Living (MEAL) Study (CALGB 70807 [Alliance]).
    Parsons JK; Pierce JP; Mohler J; Paskett E; Jung SH; Humphrey P; Taylor JR; Newman VA; Barbier L; Rock CL; Marshall J
    Contemp Clin Trials; 2014 Jul; 38(2):198-203. PubMed ID: 24837543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insignificant prostate cancer and active surveillance: from definition to clinical implications.
    Bastian PJ; Carter BH; Bjartell A; Seitz M; Stanislaus P; Montorsi F; Stief CG; Schröder F
    Eur Urol; 2009 Jun; 55(6):1321-30. PubMed ID: 19286302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expectant management with selective delayed intervention for favorable risk prostate cancer.
    Klotz L
    Urol Oncol; 2002; 7(5):175-9. PubMed ID: 12644212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer and diet: food for thought?
    Hori S; Butler E; McLoughlin J
    BJU Int; 2011 May; 107(9):1348-59. PubMed ID: 21518228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet and lifestyle can influence prostate cancer outcomes.
    Leapman MS; Clark CJ; Meng MV; Boughey JC
    Bull Am Coll Surg; 2016 Jul; 101(7):50-2. PubMed ID: 28941449
    [No Abstract]   [Full Text] [Related]  

  • 17. Lifestyle/dietary supplement partial androgen suppression and/or estrogen manipulation. A novel PSA reducer and preventive/treatment option for prostate cancer?
    Moyad MA
    Urol Clin North Am; 2002 Feb; 29(1):115-24, ix. PubMed ID: 12109339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Men's Eating and Living (MEAL) study (CALGB 70807 [Alliance]): recruitment feasibility and baseline demographics of a randomized trial of diet in men on active surveillance for prostate cancer.
    Parsons JK; Pierce JP; Mohler J; Paskett E; Jung SH; Morris MJ; Small E; Hahn O; Humphrey P; Taylor J; Marshall J
    BJU Int; 2018 Apr; 121(4):534-539. PubMed ID: 28437029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intensive lifestyle changes may affect the progression of prostate cancer.
    Ornish D; Weidner G; Fair WR; Marlin R; Pettengill EB; Raisin CJ; Dunn-Emke S; Crutchfield L; Jacobs FN; Barnard RJ; Aronson WJ; McCormac P; McKnight DJ; Fein JD; Dnistrian AM; Weinstein J; Ngo TH; Mendell NR; Carroll PR
    J Urol; 2005 Sep; 174(3):1065-9; discussion 1069-70. PubMed ID: 16094059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.